 |
|
|
|
 |
|
|
| Article 1 to 10 out of 14 concerning Katholieke Universiteit Leuven
|
-
Not the protein, but its location in the cell, determines the onset of leukemia
(07/10/2008)
Leukemia, or cancer of the bone marrow, strikes some 700 Belgians every year. Scientists are still searching for the cause of many forms of the disease, including T-cell acute lymphoblastic leukemia (T-ALL). Now, VIB researchers connected to the ...
-
Microsurgery on the brain of the fruit fly leads to new insights into irreparable nerve injuries
(06/04/2008)
Every year, one million Europeans are confronted with potentially irreparable brain or spinal cord injuries resulting from traffic accidents. Because the nerves in a damaged spinal cord cannot, or cannot fully, be repaired, the patient remains ...
-
Bart De Strooper receives prestigious USD 200,000 Alzheimer Prize
(03/04/2008)
Bart De Strooper (VIB, K.U.Leuven) has been playing a prominent role in researching the processes that underlie Alzheimer's disease. He has received widespread recognition for his work, both nationally and internationally and he received the MetLife ...
-
Progress toward an alternative for EPO: Gas6 offers remedy where EPO fails today
(02/06/2008)
Many patients with a chronic disease or cancer have to contend with anemia and the severe fatigue that accompanies anemia impedes the patient considerably in his or her daily activities. At present, the hormone EPO is administered to a large number ...
-
A major step toward a more targeted treatment for auto-immune diseases?
(01/28/2008)
More and more people in Western society are suffering from auto-immune diseases. Discovering the cause of these chronic inflammations is a first important step in the search for targeted medicines. VIB researchers connected to Ghent University and ...
-
Flemish researchers overcome oxygen deficiency
(01/09/2008)
Important medical breakthrough for organ transplants and cardiovascular diseases
When a blood vessel clogs up, a localized deficiency of oxygen results, causing the surrounding tissue to die. However, working with mice, VIB scientists connected to the Katholieke Universiteit Leuven have been able to prevent muscular tissue with ...
-
ThromboGenics Begins Preclinical Development of Anti-VPAC Antibody for Thrombocytopenia
(11/15/2007)
ThromboGenics NV announced that it will progress with the development of its novel anti-VPAC* antibody for the treatment of thrombocytopenia, including chemotherapy-induced thrombocytopenia.Thrombocytopenia, which is the reduced number of platelets ...
-
VIB and UZ-K.U.Leuven join forces and bring state-of-the-art technology to Flanders
(11/09/2007)
Genome research can now be done 100 times faster
Flemish biotechnologists have a world-wide reputation for deciphering genetic code. In order to further strengthen this leading position, two Flemish research institutes are joining forces and bringing new technology to Flanders which will record ...
-
On the road to a new cancer therapy starving the tumor
(11/02/2007)
Cancer is the major cause of death among men. Based on the current trends, scientists predict that, by about 2010, cancer will be the No. 1 cause of death for women as well. VIB scientists connected to the Katholieke Universiteit Leuven, in ...
-
Plants and stress: key players on the thin line between life and death revealed
(08/06/2007)
Our crops are not doing well these days: too much water, too little sunlight... In short, they are suffering from stress. Scientists from VIB, associated with the Katholieke Universiteit Leuven (K.U.Leuven), have revealed a new mechanism ...
|
|
|
|
|
Top
